Modulation of IL-12/IL-23 signaling pathways by ustekinumab is alleviating inflammation in Crohn´s disease patients

2018 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []